ArticleFrontiers in immunology2026

Novel involvement of LMTK2 and EML6 in rheumatoid arthritis: potential biomarkers for disease activity and seronegative patients.

Hubert Kubis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.